January 2024, Vol 312, No 7981
Top news stories
MHRA says fluoroquinolones should be administered only when no other antibiotics are appropriate
Just over half of places filled on specialist mental health training for pharmacists
Features
Measles: the vaccination rate slump fuelling an outbreak
‘Pay it forward’: enticing independent prescribers to mentor the next generation
What will the latest proposals on pharmacy supervision mean for the profession?
‘Left high and dry’: the patients pushing back against pharmacy closures
Opinion
PJ view: Training for specialist mental health pharmacists must be used — and quickly
Demand, meet supply?
Research from the depths of the ocean
Widespread pharmacogenomic testing in psychiatry needs a stronger evidence base
How our integrated care system is taking steps to minimise the risks of sodium valproate
Pharmacists are integral to launching more clinical trials in primary care
How a pharmacist-led primary care clinic can improve respiratory care
Learning & CPD
Performing a physical examination on a patient when prescribing
Test your knowledge on mental health
Overactive bladder syndrome: risk factors, diagnosis, management and medicine optimisation in older people
Sickle cell disease: causes, treatments and the patient experience
Hypertension: pharmacological management
Introducing The Pharmaceutical Journal’s prescribing collection
Your RPS
Nominate an outstanding early-career pharmacy researcher for OPERA 2024
